144 related articles for article (PubMed ID: 34113391)
1. circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways.
Wang P; Zhou C; Li D; Zhang D; Wei L; Deng Y
Oncol Lett; 2021 Jul; 22(1):563. PubMed ID: 34113391
[TBL] [Abstract][Full Text] [Related]
2. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
Li Y; Zhang J; Pan S; Zhou J; Diao X; Liu S
Thorac Cancer; 2020 Mar; 11(3):537-548. PubMed ID: 31917898
[TBL] [Abstract][Full Text] [Related]
3. CircMTO1: A circular RNA with roles in the carcinogenesis.
Ghafouri-Fard S; Khoshbakht T; Bahranian A; Taheri M; Hallajnejad M
Biomed Pharmacother; 2021 Oct; 142():112025. PubMed ID: 34392090
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the Regulatory Effect of Overexpression of circMTO1 on Proliferation and Apoptosis of Hepatoma Cells via miR-9-5p/NOX4 Axis.
Wang J; Tan Q; Wang W; Yu J
Cancer Manag Res; 2020; 12():3915-3925. PubMed ID: 32547227
[TBL] [Abstract][Full Text] [Related]
5. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
8. CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7.
Wang W; Dong R; Guo Y; He J; Shao C; Yi P; Yu F; Gu D; Zheng J
J Cell Mol Med; 2019 Aug; 23(8):5486-5496. PubMed ID: 31148365
[TBL] [Abstract][Full Text] [Related]
9. miR-219a-5p inhibits breast cancer cell migration and epithelial-mesenchymal transition by targeting myocardin-related transcription factor A.
Zhuang C; Yuan Y; Song T; Wang H; Huang L; Luo X; He H; Huo L; Zhou H; Wang N; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2017 Dec; 49(12):1112-1121. PubMed ID: 29077787
[TBL] [Abstract][Full Text] [Related]
10. circMTO1 promotes tumorigenesis and chemoresistance of cervical cancer via regulating miR-6893.
Chen M; Ai G; Zhou J; Mao W; Li H; Guo J
Biomed Pharmacother; 2019 Sep; 117():109064. PubMed ID: 31226633
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA MTO1 suppresses tumorigenesis of gastric carcinoma by sponging miR-3200-5p and targeting PEBP1.
Hu K; Qin X; Shao Y; Zhou Y; Ye G; Xu S
Mol Cell Probes; 2020 Aug; 52():101562. PubMed ID: 32194149
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor.
Cai J; Xu L; Cai Z; Wang J; Zhou B; Hu H
Mol Med Rep; 2015 Jul; 12(1):1549-55. PubMed ID: 25760482
[TBL] [Abstract][Full Text] [Related]
13. DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways.
Liu S; Chu B; Cai C; Wu X; Yao W; Wu Z; Yang Z; Li F; Liu Y; Dong P; Gong W
J Cancer; 2020; 11(18):5466-5477. PubMed ID: 32742494
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-195-5p inhibits malignant progression of gallbladder cancer by regulating Wnt3a.
Sun HD
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7635-7642. PubMed ID: 34982425
[TBL] [Abstract][Full Text] [Related]
15. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
Zhang X; Zhang L; Chen M; Liu D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.
Han D; Li J; Wang H; Su X; Hou J; Gu Y; Qian C; Lin Y; Liu X; Huang M; Li N; Zhou W; Yu Y; Cao X
Hepatology; 2017 Oct; 66(4):1151-1164. PubMed ID: 28520103
[TBL] [Abstract][Full Text] [Related]
17. circMTO1/miR-30c-5p/SOCS3 axis alleviates oral submucous fibrosis through inhibiting fibroblast-myofibroblast transition.
Bin X; Cheng JY; Deng ZY; Li B; Xu XH; Liu OS; Tang Z
J Oral Pathol Med; 2024 May; ():. PubMed ID: 38802299
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-181b-5p Inhibits the Viability, Migration, and Glycolysis of Gallbladder Cancer by Upregulating PDHX Under Hypoxia.
Qin Y; Zheng Y; Huang C; Li Y; Gu M; Wu Q
Front Oncol; 2021; 11():683725. PubMed ID: 34485121
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PVT1 regulates gallbladder cancer progression through miR-30d-5p.
Liu K; Xu Q
J Biol Regul Homeost Agents; 2020; 34(3):875-883. PubMed ID: 32689767
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
Hong H; Jiang L; Lin Y; He C; Zhu G; Du Q; Wang X; She F; Chen Y
BMC Cancer; 2016 Mar; 16():240. PubMed ID: 26992854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
